Pandit B - Search Results

1

Structure-activity relationships studies of the anti-angiogenic activities of linomide.

Shi J, Xiao Z, Ihnat MA, Kamat C, Pandit B, Hu Z, Li PK. Shi J, et al. Among authors: pandit b. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1187-9. doi: 10.1016/s0960-894x(03)00047-7. Bioorg Med Chem Lett. 2003. PMID: 12643940

2

Conformationally restricted analogs of Combretastatin A-4 derived from SU5416.

Li PK, Xiao Z, Hu Z, Pandit B, Sun Y, Sackett DL, Werbovetz K, Lewis A, Johnsamuel J. Li PK, et al. Among authors: pandit b. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5382-5. doi: 10.1016/j.bmcl.2005.09.001. Epub 2005 Oct 6. Bioorg Med Chem Lett. 2005. PMID: 16213720

3

Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416.

Pandit B, Sun Y, Chen P, Sackett DL, Hu Z, Rich W, Li C, Lewis A, Schaefer K, Li PK. Pandit B, et al. Bioorg Med Chem. 2006 Oct 1;14(19):6492-501. doi: 10.1016/j.bmc.2006.06.017. Epub 2006 Jul 24. Bioorg Med Chem. 2006. PMID: 16860559

4

Inhibitors of NF-kappaB derived from thalidomide.

de-Blanco EJ, Pandit B, Hu Z, Shi J, Lewis A, Li PK. de-Blanco EJ, et al. Among authors: pandit b. Bioorg Med Chem Lett. 2007 Nov 1;17(21):6031-5. doi: 10.1016/j.bmcl.2007.01.088. Epub 2007 Feb 2. Bioorg Med Chem Lett. 2007. PMID: 17845850

5

Design, synthesis, and studies of small molecule STAT3 inhibitors.

Bhasin D, Cisek K, Pandharkar T, Regan N, Li C, Pandit B, Lin J, Li PK. Bhasin D, et al. Among authors: pandit b. Bioorg Med Chem Lett. 2008 Jan 1;18(1):391-5. doi: 10.1016/j.bmcl.2007.10.031. Epub 2007 Oct 17. Bioorg Med Chem Lett. 2008. PMID: 18006313

6

Structure-activity relationship studies of curcumin analogues.

Fuchs JR, Pandit B, Bhasin D, Etter JP, Regan N, Abdelhamid D, Li C, Lin J, Li PK. Fuchs JR, et al. Among authors: pandit b. Bioorg Med Chem Lett. 2009 Apr 1;19(7):2065-9. doi: 10.1016/j.bmcl.2009.01.104. Epub 2009 Feb 5. Bioorg Med Chem Lett. 2009. PMID: 19249204

7

Design, synthesis and biological studies of novel tubulin inhibitors.

Sun Y, Pandit B, Chettiar SN, Etter JP, Lewis A, Johnsamuel J, Li PK. Sun Y, et al. Among authors: pandit b. Bioorg Med Chem Lett. 2013 Aug 1;23(15):4465-8. doi: 10.1016/j.bmcl.2013.04.078. Epub 2013 May 7. Bioorg Med Chem Lett. 2013. PMID: 23790539

8

Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of action.

Pandit B, Hu Z, Chettiar SN, Zink J, Xiao Z, Etter JP, Bhasin D, Li PK. Pandit B, et al. Bioorg Med Chem Lett. 2013 Dec 15;23(24):6902-4. doi: 10.1016/j.bmcl.2013.09.084. Epub 2013 Oct 4. Bioorg Med Chem Lett. 2013. PMID: 24169233

9

Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.

Lin L, Hutzen B, Zuo M, Ball S, Deangelis S, Foust E, Pandit B, Ihnat MA, Shenoy SS, Kulp S, Li PK, Li C, Fuchs J, Lin J. Lin L, et al. Among authors: pandit b. Cancer Res. 2010 Mar 15;70(6):2445-54. doi: 10.1158/0008-5472.CAN-09-2468. Epub 2010 Mar 9. Cancer Res. 2010. PMID: 20215512 Free PMC article.

10

A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.

Li PK, Pandit B, Sackett DL, Hu Z, Zink J, Zhi J, Freeman D, Robey RW, Werbovetz K, Lewis A, Li C. Li PK, et al. Among authors: pandit b. Mol Cancer Ther. 2006 Feb;5(2):450-6. doi: 10.1158/1535-7163.MCT-05-0254. Mol Cancer Ther. 2006. PMID: 16505120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page